FDA approves pancreatic cancer drug that extends patients’ lives – The Washington Post

FDA approves pancreatic cancer drug that extends patients’ lives  The Washington PostF.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer  The New York TimesPancreatic cancer drug approved by FDA is “exceptional moment,” Boston researcher says  CBS NewsFDA approves once-daily pill for deadly cancer after patients’ survival rates nearly double  Fox NewsA Breakthrough Pancreatic Cancer Drug Marks a New Era for Treatment  Bloomberg.com